
zzso zzso have become an important new class of therapeutic agents approved for use in solid zzso They function through several different mechanisms including zzso of zzso signal zzso induction of zzso zzso of zzso enhancing host immune response against cancer and targeted delivery of zzso agents to the tumor zzso Several zzso zzso have now received regulatory zzso zzso zzso zzso zzso zzso and zzso multiple solid tumor types, including breast, zzso head and neck, zzso cell lung zzso and zzso amongst zzso These agents are employed clinically in some zzso and radical treatment settings, as well as more extensively in the zzso and zzso zzso Current research is focused on innovative compound design, novel targets, zzso zzso discovery, enriched patient zzso and combination strategies in order to overcome resistance and prolong disease zzso Here we provide an overview of zzso zzso approved for use in clinical zzso and those currently in clinical zzso 

